TRIN Trinity Capital Inc.
Trinity Capital Inc. is a business development company specializing in term loans, equipment financing, and private equity-related investments. The firm provides tech lending, equipment financing, life sciences, warehouse lending, and sponsor finance sources. The firm is industry agnostic and invests in growth-stage companies across industries, including aerospace, software, Agricultural Equipment, Alternative Protein, Clean Technology, Energy, Food and Beverage / CPG, Information Technology, Life Sciences, Oil and Gas, Robotics, Semiconductors, Transportation, and consumer and retail. They provide investors with stable and consistent returns through access to the private credit market. Trinity Capital Inc. was founded in 2008 and is based in Phoenix, Arizona, with additional offices in Solana Beach, California and San Diego, California.…
Industry Peers
Asset ManagementKey Statistics
About Trinity Capital (NYSE: TRIN)
›
Trinity Capital (NYSE: TRIN) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Asset Management industry, part of the Financial Services sector, and reports about 119 employees.
The shares were at 17.70 USD on 13 November 2026, up 34.7% over 52 weeks. Its 52-week range is 14.13 USD to 18.89 USD: the price is 6.3% below the high and 25.3% above the low.
At a market capitalisation of 1.75B USD, it trades at 9.5 times trailing earnings and 8.4 times forward earnings. The median trailing P/E of its 18 largest Asset Management peers is 15.8, a discount of 40% for TRIN. It pays a dividend yielding 11.42% (it pays out 109% of its earnings), against a median of 1.73% among the dividend payers in that peer group.
Trinity Capital reports return on equity of 12.4%, an operating margin of 75.6% and revenue up 18.4% year over year.
Its debt exceeds its cash by 1.54B USD, a debt-to-equity ratio of 1.18. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. 9 analysts cover the stock, with an average rating of Buy; their mean price target of 19.00 USD is 7.3% above the current price. The next earnings report is expected on 24 February 2027.